Swiss

Swiss Hyperloop Team Achieves Top Position at Not-a-Boring Competition

Retrieved on: 
Friday, September 17, 2021

Teams faced immense logistical challenges to compete in the "Not-A-Boring Competition" amid a global pandemic and labor shortages.

Key Points: 
  • Teams faced immense logistical challenges to compete in the "Not-A-Boring Competition" amid a global pandemic and labor shortages.
  • The Hyperloop competition was an ideal opportunity for Gebrder Weiss to put our company values into action.
  • Behind Swissloop Tunneling is a team of students from the Swiss Federal Institute of Technology (ETH) Zurich researching and developing tunneling solutions for Hyperloop technology.
  • Swissloop Tunneling and eleven other teams qualified from among 400 applicant teams to participate in the competition.

Foresters Financial partners with global Insurtech dacadoo to launch innovative well-being technology platform

Retrieved on: 
Monday, September 13, 2021

The innovative wellness platform integrates wearable app-enabled technology and behavioral science to inspire and reward healthy lifestyles.

Key Points: 
  • The innovative wellness platform integrates wearable app-enabled technology and behavioral science to inspire and reward healthy lifestyles.
  • Earlier this year, Foresters announced it had teamed up with dacadoo AG (dacadoo) an award-winning Insurtech specializing in digital health engagement and health risk quantification to design Foresters Go exclusively for Foresters members.
  • Working with dacadoo, Foresters customized Foresters Go based on feedback from over one thousand pilot participants made up of members, advisors and employees.
  • Foresters Financial is the trade name for The Independent Order of Foresters, the oldest non-denominational fraternal benefit society.

EQS-News: Closing of Prosecutor's Investigation Regarding the Covid-19 Credit of Terraoil Swiss AG

Retrieved on: 
Thursday, September 2, 2021

On August 30, 2021, the Company received the investigation closing order (Einstellung) from the Prosecutor's Office.

Key Points: 
  • On August 30, 2021, the Company received the investigation closing order (Einstellung) from the Prosecutor's Office.
  • An official press release from the Prosecutor's Office on the closing of the investigation can be accessed here .
  • Meanwhile, the Board of Directors has also reviewed the Company's compliance policies, procedures, and internal controls in light of the investigation.
  • The forward-looking statements contained in this media release are based on the views and assumptions of Terraoil Swiss AG as of this date and Terraoil Swiss AG does not assume any obligation to update or revise this media release.

Daniela Drago Joins Aurion Biotech as Chief Regulatory Officer

Retrieved on: 
Tuesday, August 10, 2021

Aurion Biotech , whose mission is to cure blindness by developing a differentiated platform of advanced therapies to treat ocular diseases, today announced it has appointed Daniela Drago, MS, PhD, RAC, as chief regulatory officer.

Key Points: 
  • Aurion Biotech , whose mission is to cure blindness by developing a differentiated platform of advanced therapies to treat ocular diseases, today announced it has appointed Daniela Drago, MS, PhD, RAC, as chief regulatory officer.
  • View the full release here: https://www.businesswire.com/news/home/20210810005233/en/
    Daniela Drago, Aurion Biotech Chief Regulatory Officer (Photo: Business Wire)
    A natural-born leader, Daniela brings to Aurion Biotech both broad and deep insights - not only in ophthalmology, but also cell therapies, gene therapies and biologics, said Greg Kunst, chief executive officer of Aurion Biotech.
  • Dr. Drago joins Aurion Biotech from Biogen, where she led the regulatory team responsible for development products in the United States.
  • The Aurion Biotech team is preparing for clinical trials in the U.S. To learn more about Aurion Biotech, a division of CorneaGen Inc., visit www.aurionbiotech.com .

Swisspod Launches World's First Infinite Trajectory Hyperloop Testing Facility

Retrieved on: 
Friday, July 23, 2021

Swisspod and its esteemed academic partner are collaborating on the development of an operational field-test facility for the validation of ultra-fast transportation solutions.

Key Points: 
  • Swisspod and its esteemed academic partner are collaborating on the development of an operational field-test facility for the validation of ultra-fast transportation solutions.
  • The facility hosts an "infinite" Hyperloop track used for the testing and validation of Swisspod's novel and highly efficient propulsion system design.
  • Swisspod and the Swiss Federal Institute of Technology in Lausanne (EPFL), one of Europe's most prestigious research universities, are extending their longstanding collaboration with the development of an operational testing facility for ultra-fast transportation solutions.
  • Swisspod is a Swiss B2B transportation technology company leading the development of the most sustainable, efficient and comprehensive Hyperloop solution.